Drugs / recomon
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01111630 Comparator | Oct 2009 → Oct 2013 | anemia, chronic renal failure syndrome | JW Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recomon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01111630 ↗ |
| Known as | Epoetin Beta | “recomon (Epoetin Beta)” NCT01111630 ↗ |